Heranba Industries Ltd
Incorporated in 1994, Heranba Industries Ltd is engaged in the manufacturing of a diverse range of agrochemicals such as insecticides, herbicides, fungicides and public health products for pest control. [1]
- Market Cap ₹ 1,417 Cr.
- Current Price ₹ 354
- High / Low ₹ 543 / 265
- Stock P/E 31.4
- Book Value ₹ 207
- Dividend Yield 0.36 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2023 | TTM | |
---|---|---|
1,319 | 1,236 | |
1,163 | 1,151 | |
Operating Profit | 156 | 85 |
OPM % | 12% | 7% |
12 | 11 | |
Interest | 8 | 10 |
Depreciation | 23 | 24 |
Profit before tax | 138 | 63 |
Tax % | 24% | |
104 | 45 | |
EPS in Rs | 26.08 | 11.28 |
Dividend Payout % | 5% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -35% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2023 | Sep 2023 | |
---|---|---|
Equity Capital | 40 | 40 |
Reserves | 770 | 787 |
93 | 88 | |
259 | 466 | |
Total Liabilities | 1,162 | 1,381 |
209 | 218 | |
CWIP | 72 | 165 |
Investments | 1 | 1 |
881 | 997 | |
Total Assets | 1,162 | 1,381 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2023 | |
---|---|
0 | |
0 | |
0 | |
Net Cash Flow | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2023 | |
---|---|
Debtor Days | 107 |
Inventory Days | 126 |
Days Payable | 78 |
Cash Conversion Cycle | 154 |
Working Capital Days | 131 |
ROCE % |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Investor Presentation 8 Nov
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
8 Nov - Press Release dated November 08, 2023 on Acquisition
-
Announcement under Regulation 30 (LODR)-Acquisition
8 Nov - Mikusu India Private Limited ( Mikusu or Acquirer), a Wholly owned Subsidiary of Heranba Industries Limited ( Company) has entered into Share Purchase Agreement dated …
- Closure of Trading Window 8 Nov
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
4 Nov - Results for the quarter ended September 30, 2023, has been published in the Newspapers, the details of which are given in the letter attached herewith.
Annual reports
Concalls
-
Nov 2023TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Jan 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
Product Portfolio
The Co.’s portfolio comprises intermediates, technicals and formulations.
Intermediates: Intermediates manufactured are for Co.’s own captive consumption for manufacturing various Technicals and Formulations. [1] These include CMAC, Bromobenzenes, Metaphenoxy, etc.
Technicals: These include Cypermethrin, Deltamethrin, Alpha Cypermethrin, Acephate, Lambda Cyhalothrin, etc.
Formulations: Formulations and branding of formulations are a forward integration to Heranba’s technical business. These include Emulsifiable Concentrate (EC), Water Dispersible Granule (WDG), Suspension concentrate, Capsule Suspension (CS), etc.
It has 400 product registrations in 49 countries,210 registrations in pipeline in 49 countries. 24 Technicals,193 formulations are registered for manufacture & sale in India.68 technicals & 65 formulations are registered for manufacture and sale in export markets
{#https://www.bseindia.com/bseplus/AnnualReport/543266/73414543266_05_07_22.pdf#page=4 #}